Aebi Schmidt heads into its third-quarter report with an awkward split between what the business is doing and what the stock is doing. Last quarter management described another substantial step forward: faster organic growth, order intake up 16%, a backlog of roughly $1.3 billion and EBITDA climbing faster than sales. Yet the shares have fallen 13.6% since that report, trailing the S&P 500 by nearly 11 percentage points. The likeliest explanation is the one blemish management volunteered on the call. Tariff-driven material costs and higher energy prices are squeezing gross margin, and price increases will take until late 2026 or early 2027 to catch up. This report should show how much that squeeze is costing.

The Street expects earnings of $0.22 a share on revenue of about $519.6 million, both reported before the market opens on November 11. Revenue would be up 10.2% from a year ago. That is solid but not spectacular, and it roughly matches the 9.4% organic pace management reported in the second quarter. The roughly elevenfold jump in EPS mostly reflects how little the company earned a year ago, just $0.02. Against last quarter's $0.14, the bar still implies a meaningful step up in profit. Full-year consensus of $2.03 billion sits close to the middle of management's reaffirmed $1.95 billion to $2.15 billion range. So the Street is not asking for a raise, only steady progress.

The central question is whether operating leverage survives the cost inflation. In the second quarter adjusted EBITDA rose 22% and margin widened about 90 basis points to 8.5%. Synergy capture is a big part of that. Management lifted its merger target to more than $40 million in run-rate savings and expects about $37 million realized by year-end, up from the mid-teens in 2025. If EBITDA margin holds near or above 8.5% while gross margin absorbs the cost hit, synergies are doing their job and the earnings case stays intact. If margin slips back toward last year's levels, investors will start to doubt the bridge to the Strategy 2030 target of an EBITDA margin above 13%.

Orders matter nearly as much. The fourth quarter of 2025 brought a 46% surge in bookings, and the second quarter added 16% on top of that. Order intake that stays comfortably above sales would support the view that the backlog is a growth engine rather than a one-time catch-up. It would also make the delayed price increases less worrying, since newer orders carry better pricing. Recent wins, including a UK airport supply deal, a German motorway contract and early cross-selling of service bodies, are worth tracking for signs of broader commercial traction. Investors will also want updates on the $96 million walk-in van frame contract and the shift away from Ford chassis, even though that contract does not produce revenue until 2027. Truck bodies and commercial markets have been the historical soft spots, and any renewed weakness there would undercut the growth story.

The balance sheet is the other pressure point. Management softened its year-end leverage goal from two times or slightly below to two times or slightly above, blaming safety stock and working capital that will linger into early 2027. Leverage stood at 2.7 times last quarter. Steady progress toward that target, along with any sign that inventory is starting to peak, would ease concerns that the cost problem is also tying up cash.

Sentiment has warmed sharply, rising from near neutral before the last report to solidly bullish now. The stock tells a more cautious story. At $11.79 it sits below its 200-day moving average of $12.40 and in the lower half of its post-earnings range of $10.33 to $14.95. That combination leaves room for a rebound if margins hold, but little patience if they don't. The thesis survives if EBITDA keeps outgrowing sales despite inflation. If cost pressure overwhelms synergies, the strong backlog will matter much less.